chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Twelve days after the booster shot (third shot) I broke out in a rolling rash starting on the tops of my feet and the palms of my hands and the back of my elbows. It was very itchy and woke me in the nighttime. I would break out in different locations on my arms, back neck, scalp and mid-torso and occasionally on my thighs. Topical creams did not help. I contacted my physician who had me take Claritin  once a day and Benadryl at night. Still the rash and itchiness did not subside. After seeing her I was put on a 5-day regimen of prednisone which did help. But for a week after completing that dosage I still needed to take the Claritin and for several days the Benadryl. Still I break out in red patches on my torso or neck, but there is no rash and no itchiness. It is as if my skin remembers the irritation and reacts.
Fever for 3 days with onset of "chicken pox" type rash on 12/12/2003.  Marks on 12/15/03.  Started to clear today 12/16/03.  Mom estimates greater than 50 pox on face/abdomen.
20 mins after receiveing vaccine pt had difficulty breathing, she took BENADRYL and used an EPIPEN that she had at home then took ambulance to emergency room.
Severe red rash on both legs in the evening of April 1st. It subsided by morning of the nest day.   I treated it with lotion which eased the itching and burning.
Approximately 4 to 6 months after the 2nd 30 day shot I experienced severe pain and stiffness in my right knee joint. This seemed to subside and then in about 6 months the same thing happened to my left hip joint and then my right shoulder joint and eventually to my left hip joint, again.
3/19  Resting Pulse 105-120,  Walking Pulse 120-140,  Pulse Ox:  95,  Temp: 100.0 3pm ,101.1 4pm.  Throbbing on and off head aches in Parietal, and Frontal Lobes, started at 5-6PM.  Upper body Pain in joints and lymphatic system.   Lower Body pain in Right knee at 8pm.  Renal/Flank pain most likely due to dehydration.    Memory confusion and General Confusion, dizziness, foggy memory.  Swollen Right Deltoid, subcutaneous heat at the injection site that can be felt through a polo shirt.  3/20- Flank and Kidney Pain.  Memory confusion and General Confusion and Foggy memory still remains .  Swollen Right Deltoid, subcutaneous heat at the injection site that can be felt through a polo shirt.  3/22- Memory confusion and General Confusion and Foggy memory still remains.  Swollen Right Deltoid, subcutaneous heat at the injection site that can be felt through a polo shirt still present.  3/20- Memory confusion seems to be improving but foggy memory still remains.  Swollen Right Deltoid, subcutaneous heat at the injection site that can be felt through a polo shirt still present.
Pt woke up day after vaccine with itchiness on her chest, throughtout the day the itching did not go away.  Woke up Wednesday with rash all over chest area.  No rash elsewhere on body.   Reported to employee health and was told to take benadryl and if rash continued to contact my primary care provider.
I have had hives on a d off every day for a month. Started exactly 2 weeks after my booster shot of moderna. Never had hives before.  I went to urgent care and received triamcinolone cream for affected areas and Zyrtec daily.  Zyrtec helps but as soon as it wears off, the hives come back in random places on my body.
Recieved prevnar # 4 on 6/16/08.  Stared on 6/18/08 wilth left thigh redness, area warm to touch.  Seen in our office for eval and diagnosed with cellulitis.  Treated with Keflex.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown demographics. The concurrent condition, medical history and concomitant medication was not reported. On 01-JUL-2015 the patient was inadvertently vaccinated with VARIVAX (Merck) which was expired on 30-JUN-2015. No adverse effects was reported. Additional information has been requested.
Fall against object - ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Light headed, body felt light it was burning up, sweating continuously, speech started sluring, eyes rolled back, vomiting, and lost control of my bowls.
pt recvd vax & had a syncopal or vasovagal episode; pt recovered w/o any residula effects; No further details were provided; MD reported 20 pts;
p/vax pt devel tightness in chest & flushing;pt given DPH in MD office & recovered;this event is considered medically significant;
Itchy rash; COVID arm; pinkish-reddish discoloration of the underside of forearms; Rash from neck down; Stinging rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (Itchy rash), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE DISCOLOURATION (pinkish-reddish discoloration of the underside of forearms), RASH (Rash from neck down) and RASH (Stinging rash) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008b212a and 014m20a) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction (Ragweed and bees). Concurrent medical conditions included Blood pressure, Gout and Fibromyalgia.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced RASH PRURITIC (Itchy rash), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE DISCOLOURATION (pinkish-reddish discoloration of the underside of forearms), RASH (Rash from neck down) and RASH (Stinging rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Itchy rash), VACCINATION SITE DISCOLOURATION (pinkish-reddish discoloration of the underside of forearms), RASH (Rash from neck down) and RASH (Stinging rash) had resolved and VACCINATION SITE REACTION (COVID arm) outcome was unknown.            Concomitant medications include Blood pressure medication, Gout medication and Fibromyalgia medication.  Patient was checked out by an EMT at the clinic and took two Benadryl. She had no breathing problems and ended up going home. She says the rash was itchy. She let her practitioner know, who said to keep taking Benadryl for the rash. She says she took Benadryl every 4-6 hours for a couple days, then every 12 hours for a couple more days.   This case was linked to US-MODERNATX, INC.-MOD-2021-071363 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Follow-up included outcome of the event rash, rash pruritic was updated to not recovered and treatment drug frequency was updated. On 12-May-2021: Outcome of events( Rash and vaccination site discolouration ) changed to Recovered.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071363:First dose case
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE DVT OF LEFT FEMORAL VEIN 10/14/2022 --- RECURRENCE OF SAME SYMPTOMS
PASSED AWAY; STROKES; BLOOD CLOTS; This spontaneous report received from a consumer via a company representative via social media concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the reporter stated that, "Just had two coworkers in three weeks of each other got strokes and blood clots one is still in Intensive care unit the other sadly passed away this weekend". On an unspecified date, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of passed away on an unspecified date, and the outcome of strokes and blood clots was not reported. This report was serious (Death, and Other Medically Important Condition). This case, from the same reporter is linked to 20220234488.; Sender's Comments: V0:20220234166- covid-19 vaccine ad26.cov2.s-passed away, strokes and blood clots. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with a dose of GARDASIL (strength reported as 120 microgram, dose, lot# and expiration date not reported) that was exposed to 20 F for an unspecified period of time, which was excursion that was unsupported by in-house stability data. No adverse symptoms were reported. Follow up information has been received on 24-APR-2014 from a nurse. The reporter mentioned that "30 patients or less" received improperly stored GARDASIL that was exposed to 20F for 11 days. Administration dates, lot # and expiration dates were not reported. Follow up information was received a health center manager. The patients identifiers were obtained. This report concerns one of the patients. On 14-JAN-2014, at 13:15 PM, the 27 year old female patient was vaccinated with the third dose of GARDASIL (lot # J005661) into left deltoid (dose, route not reported). The medication refrigerator was out of range on the following dates: Jan 07, temperature (Degrees Fahrenheit) 44/26; Jan 09, 36/22; Jan 11, 26/40; Jan 14, 22/26. This is one of several reports received from the same source. Additional information is not expected.
Area where shot administered (5 in diameter) was red and swollen. Pain experienced down through elbow and into armpit. Patient unable to lift arm above head
Fever and onset of seizures with severe neurological disease, which initially was thought to be ADEM. Work-up is ongoing.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical histories, drug reactions or allergies and concomitant therapies was provided. On 28-JAN-2017, 29-JAN-2017 and 30-JAN-2017, the patients were vaccinated with improperly stored doses of ROTATEQ orally, lot # L035510 with expiry date of 13-MAY-2017 (dose was not reported). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion of below 32 degrees Fahrenheit (with minimum temperature of 25 degrees Fahrenheit) for 14 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA014176.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 22-APR-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ, lot # L027076, expiration date 25-MAY-2017 (dose was not reported) and PEDVAXHIB lot # L035880, expiration date 11-AUG-2018 (dose and route of administration were not reported). There was no adverse effect reported. No product quality issue was involved. Administered dose of vaccine experienced the temperature excursion of low - 28 degrees Fahrenheit for 5 hours on 22-APR-2016. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Moderna COVID-19 Vaccine EUA The evening of the day I received the vaccine my left anterior-distal leg had what looked like bruising.  Also, the left distal anterior and medial leg, left ankle and dorsum of left foot became edematous.  It was also painful.  I still have edema to this date in the area just described.  Pain has resolved.   In late 2018 I had bilat lower extremity endovascular radiofrequency ablations secondary to CVI with severe varicosities.
Postmenopausal bleeding. Started spotting 3/12/21. Heavy bleeding started April 28, 2021. Still bleeding for 2 weeks.
seeing double; vertigo; nausea; redness around injection site; tenderness around injection site; headache; side of face including ear felt clogged; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache), FEELING ABNORMAL (side of face including ear felt clogged) and DIPLOPIA (seeing double) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Osteoporosis and Cancer. Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included AMLODIPINE, ACETYLSALICYLIC ACID (ASPIRIN 81), ATORVASTATIN, CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM CARBONATE AND VITAMIN D), MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC), SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), LEVOTHYROXINE, FISH OIL, TOCOPHEROLS MIXED (OMEGA 3 2100), VALSARTAN, ASCORBIC ACID, ZINC (VITAMIN C + ZINC), VITAMIN D3, LEVOFLOXACIN (LEVOMIR) and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache) and FEELING ABNORMAL (side of face including ear felt clogged). On 26-Jan-2021, the patient experienced DIPLOPIA (seeing double), VERTIGO (vertigo) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache), FEELING ABNORMAL (side of face including ear felt clogged), DIPLOPIA (seeing double), VERTIGO (vertigo) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
pt recv vax & had itching but no DPH was needed;pt exp hair loss on crown about the size of a nickel;pt feels that hair is thinner & notices more hair on brush;
Vasovagal response without syncope. Patient noted anxiety prior to administration of vaccination. Patient became dizzy, had change in vision and hearing without loss of consciousness after administration of vaccination.  Alert and responsive immediately after episode. Vital signs stable at repeat check 10 minutes later. No symptoms after reevaluation and patient discharged to home 15 minutes after episode.
Day 2, red swollen feverish injection site size of a large lemon and a bad headache like I had when I had Covid. Fever 100. Same on 3rd day and towards evening my neck on left side felt weird. I woke up this morning with swollen lymph node on left neck and glands tender when I try to eat or drink.
Received call from PMC office that pt had gone there 2 days after vaccine administration with induration (R) arm 16 cm x 11 cm and temp increased 101. Treated with KEFLEX x 10 days.
Patient received shots 7/26/21-Prevnar, Havrix, Pedvax Hib, Proquad. Rash on trunk, upper thighs, few on face; maculopapular, erythema , mild itching, no fever, redness, eating well. Pt. well appearing and seems unremarkable except for rash.
Apparent vaccine failure:  patient broke out with lesions late in the day on 5/10/04.  By 5/11/04, I saw evidence of several hundred lesions (over 300) and offered acyclovir.  Patient took acyclovir starting 5/12.  She had two syncopal episodes, on 5/11, and 5/13.  The lesions faded quickly after initiation of acyclovir.  A number of other children who were also vaccinated in the community also developed chicken pox at the same time, according to the patient's family.
BACK PAIN; PAIN IN BOTH LEGS; BODY PAIN; ANXIOUS; This spontaneous report received from a patient concerned a 26 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol use, and cigarette smoker. The patient experienced drug allergy when treated with codeine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 14-MAY-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On MAY-2021, the subject experienced anxious. On 14-MAY-2021, the subject experienced body pain. On 15-MAY-2021, the subject experienced back pain. On 15-MAY-2021, the subject experienced pain in both legs. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body pain, pain in both legs, and back pain, and the outcome of anxious was not reported. This report was non-serious.
Anaphylaxis after taking Ibuprofen. I have taken Ibuprofen for many years as my pain-reliever of choice for headache, muscle pain etc. Suddenly I am allergic to it, and it is deadly.
Started feeling sore and painful for about 3-4 days in left arm where vx was given.
Costochondritis diagnosis due to four days of trouble breathing and pain in chest; Costochondritis diagnosis due to four days of trouble breathing and pain in chest; Costochondritis diagnosis due to four days of trouble breathing and pain in chest; This is a spontaneous report from a contactable consumer (patient).A 22-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), via an unspecified route of administration, administered in Arm Left on 05May2021 17:00 (at the age of 22-years-old) (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing Known allergies: Meloxicam and other NSAIDS. Concomitant medications included oxymetazoline hydrochloride (CLARITIN ALLERGIC), ethinylestradiol, norethisterone (NORTREL [ETHINYLESTRADIOL NORETHISTERONE], sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. The patient previously took meloxicam for drug hypersensitivity. On 05May2021 18:00, the patient experienced costochondritis diagnosis due to four days of trouble breathing and pain in chest.The AE resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with 1g Tylenol three times daily and warm compresses. The patient did not have covid prior vaccination. The patient was tested for covid post vaccination.The patient underwent lab tests and procedures which included sars-cov-2 test: pending on 09May2021. Outcome of events was not recovered.  No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Pain moved from different locations sometimes on and off; Couldn't stand up or move; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), PAIN (Pain moved from different locations sometimes on and off) and FATIGUE (Couldn't stand up or move) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced BACK PAIN (Back pain) and FATIGUE (Couldn't stand up or move). On an unknown date, the patient experienced PAIN (Pain moved from different locations sometimes on and off). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, BACK PAIN (Back pain), PAIN (Pain moved from different locations sometimes on and off) and FATIGUE (Couldn't stand up or move) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
chills, myalgias, (L) arm swelling x 24 hrs; stiff neck persisting until present time (12/12/07 0800). Pt instructed to RTc no improving or worsening myalgia; ok to take ibuprofen prn
8/21/2012 After leaving office, mom noticed that she favored (R) leg. Pt refuses to bend leg, knee, fusses & whines when mom attempts to bend knee. Favors (R) leg. No fever, lumps, redness or swelling. Adverse reaction to left leg.
This spontaneous report was received from a physician via Pfizer regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medication were unknown. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, route, lot # and expiry date not reported) for prophylaxis. On an unknown date, the patient experienced drug allergies with PNEUMOVAX 23. The outcome of drug hypersensitivity was unknown. Causality assessment for the event was not provided by the reporter.
Patient was brought to the ED by EMS on 1/18/23 for evaluation after an episode in which she felt weak, confused, and sweaty, and staff at her home reported she had a little garbled speech. By the time EMS arrived on the scene, patient was neurologically intact. There was concern for possible TIA so she came into the ED for evaluation. She was admitted 1/18/23 for further evaluation of her presentation. On 1/19, the patient was noted to have a cough and reported increasing URI symptoms, so a COVID PCR test was performed which resulted positive. During her admission, she did not require supplemental O2. Her mentation improved during admission, and the provider suspected that her weakness and confusion were due to metabolic encephalopathy secondary to COVID-19 illness.  Patient was discharged 1/21/23 to transitional care.  She has received the primary COVID vaccine series and booster x3.